Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS

AAPS PharmSciTech

Volumn 10, Issue 4, 2009, Pages 1172-1177

  Al Obaidi, Hisham ^a   Buckton, Graham ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Amorphous solid dispersion; Dissolution rate; Hydrogen bonding; PHPMA; Spray drying HPMCAS

Indexed keywords

CARBONYL DERIVATIVE; GRISEOFULVIN; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; POLY[N (2 HYDROXYPROPYL)METHACRYLATE]; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DISPERSION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; DRUG SYNTHESIS; GLASS TRANSITION TEMPERATURE; HYDROGEN BOND; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; SPRAY DRYING; X RAY POWDER DIFFRACTION;

ANTIFUNGAL AGENTS; CRYSTALLIZATION; DRUG STABILITY; GRISEOFULVIN; HYDROGEN BONDING; METHYLCELLULOSE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE;

EID: 75549091727     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9319-x     Document Type: Article

References (18)

1. PN Elliott JL Ford KK Chan 1984 The effect of incorporation of indomethacin with polyethylene glycol 6000 in a solid dispersion on its in vivo properties in the rat Agents Actions 15 367 370 10.1007/BF01972373 1:CAS:528:DyaL2cXmtlGntbo%3D 6524525 (Pubitemid 15188257)
2. MJ Park S Ren BJ Lee 2007 In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion Biopharm Drug Dispos 28 199 207 10.1002/bdd.546 1:CAS:528:DC%2BD2sXlslSisbs%3D 17377960 (Pubitemid 46824855)
3. BM Tashtoush ZS Al-Qashi NM Najib 2004 In vitro and in vivo evaluation of glibenclamide in solid dispersion systems Drug Dev Ind Pharm 30 601 607 10.1081/DDC-120037491 1:CAS:528:DC%2BD2cXksFSgtro%3D 15285333 (Pubitemid 38924630)
4. GL Amidon H Lennernas VP Shah JR Crison 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm Res 12 413 420 10.1023/A:1016212804288 1:CAS:528:DyaK2MXksVGqur8%3D 7617530
5. KP Chowdary SS Rao 2000 Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants Drug Dev Ind Pharm 26 1207 1211 10.1081/DDC-100100993 1:CAS:528:DC%2BD3cXnvVSnurg%3D 11068695 (Pubitemid 30807507)
6. WL Chiou S Riegelman 1971 Pharmaceutical applications of solid dispersion systems J Pharm Sci 60 1281 1302 10.1002/jps.2600600902 1:STN:280: DyaE3M3otFersQ%3D%3D 4935981
7. M Fujii H Okada Y Shibata H Teramachi M Kondoh Y Watanabe 2005 Preparation, characterization, and tableting of a solid dispersion of indomethacin with crospovidone Int J Pharm 293 145 153 10.1016/j.ijpharm.2004. 12.018 1:CAS:528:DC%2BD2MXitlSgtLs%3D 15778052 (Pubitemid 40381088)
8. S Sethia E Squillante 2004 Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods Int J Pharm 272 1 10 10.1016/j.ijpharm.2003.11.025 1:CAS:528:DC%2BD2cXhs1Giurw%3D 15019063 (Pubitemid 38293005)
9. RJ Chokshi H Zia HK Sandhu NH Shah WA Malick 2007 Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution: pros and cons Drug Deliv 14 33 45 10.1080/10717540600640278 1:CAS:528:DC%2BD2sXptlynsg%3D%3D 17107929 (Pubitemid 44764457)
10. Buckton G, Brocchini S, Fletcher J, Al-Obaidi H. Solid dispersion of hydrophobic bioactive. 2006; PCT/GB2006/000467
11. Al-Obaidi H, Brocchini S, and Buckton G. Anomalous properties of spray dried solid dispersions. J Pharm Sci. 2009. doi: 10.1002/jps.21782.
12. LR Hilden KR Morris 2004 Physics of amorphous solids J Pharm Sci 93 3 12 10.1002/jps.10489 1:CAS:528:DC%2BD2cXjvFWhug%3D%3D 14648630 (Pubitemid 38087927)
13. R Nair N Nyamweya S Gonen LJ Martinez-Miranda SW Hoag 2001 Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation Int J Pharm 225 83 96 10.1016/S0378-5173(01)00767-0 1:CAS:528:DC%2BD3MXlslant7Y%3D 11489557 (Pubitemid 32728202)
14. SW Kuo CC Shih JS Shieh FC Chang 2004 Specific interactions in miscible polymer blends of poly(2-hydroxypropyl methacrylate) with polyvinylpyrrolidone Polym Int 53 218 224 10.1002/pi.1271 1:CAS:528:DC%2BD2cXotF2itw%3D%3D (Pubitemid 38162533)
15. LS Taylor G Zografi 1998 Sugar-polymer hydrogen bond interactions in lyophilized amorphous mixtures J Pharm Sci 87 1615 1621 10.1021/js9800174 1:CAS:528:DyaK1cXlslaqsbk%3D 10189276 (Pubitemid 28559651)
16. F Cilurzo P Minghetti A Casiraghi L Montanari 2002 Characterization of nifedipine solid dispersions Int J Pharm 242 313 317 10.1016/S0378-5173(02) 00173-4 1:CAS:528:DC%2BD38Xmt1ynsLc%3D 12176270 (Pubitemid 34899479)
17. M Mosharraf C Nystrom 2003 Apparent solubility of drugs in partially crystalline systems Drug Dev Ind Pharm 29 603 622 10.1081/DDC-120021310 1:CAS:528:DC%2BD3sXls1Kqtr4%3D 12889779 (Pubitemid 36835154)
18. R Takano K Furumoto K Shiraki N Takata Y Hayashi Y Aso S Yamashita 2008 Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation Pharm Res 25 2334 2344 10.1007/s11095-008-9637-9 1:CAS:528:DC%2BD1cXhtFOru77K 18560998